High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from? ; volume:17 ; number:1 ; day:6 ; month:1 ; year:2017 ; pages:1-10 ; date:12.2017
BMC infectious diseases ; 17, Heft 1 (6.1.2017), 1-10, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Ragonnet, Romain
- Contributor
-
Trauer, James M.
Denholm, Justin T.
Marais, Ben J.
McBryde, Emma S.
SpringerLink (Online service)
- DOI
-
10.1186/s12879-016-2171-1
- URN
-
urn:nbn:de:1111-201702024289
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ragonnet, Romain
- Trauer, James M.
- Denholm, Justin T.
- Marais, Ben J.
- McBryde, Emma S.
- SpringerLink (Online service)
Other Objects (12)
Multidrug-resistant tuberculosis
Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis
Nomogram to predict multidrug-resistant tuberculosis
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Efficient Photolysis of Multidrug‐Resistant Polymicrobial Biofilms
Multidrug-resistant Mycoplasma genitalium infections in Europe
Characteristics of multidrug-resistant tuberculosis in Namibia
Nanocatalytic materials against multidrug-resistant bacterial infection
Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Overcoming Multidrug‐Resistant MRSA Using Conventional Aminoglycoside Antibiotics
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
Multidrug-resistant tuberculosis
Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis
Nomogram to predict multidrug-resistant tuberculosis
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Efficient Photolysis of Multidrug‐Resistant Polymicrobial Biofilms
Multidrug-resistant Mycoplasma genitalium infections in Europe
Characteristics of multidrug-resistant tuberculosis in Namibia
Nanocatalytic materials against multidrug-resistant bacterial infection
Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Overcoming Multidrug‐Resistant MRSA Using Conventional Aminoglycoside Antibiotics
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
Multidrug-resistant tuberculosis
Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis
Nomogram to predict multidrug-resistant tuberculosis
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Efficient Photolysis of Multidrug‐Resistant Polymicrobial Biofilms
Multidrug-resistant Mycoplasma genitalium infections in Europe
Characteristics of multidrug-resistant tuberculosis in Namibia
Nanocatalytic materials against multidrug-resistant bacterial infection
Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Overcoming Multidrug‐Resistant MRSA Using Conventional Aminoglycoside Antibiotics
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa